mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.002 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |